Movement Alert|Teradyne Falls 3.27% in Regular Trading, Baird Downgrades Rating to Neutral from Outperform

Market Focus
Aug 21

On August 21, Teradyne fell 3.27% in regular trading, trading at $371.31/share, with turnover of $125 million. The decline was triggered by Baird downgrading the stock from Outperform to Neutral while maintaining a price target of $420.

Baird had previously lowered its price target on Teradyne from $446 to $420 on July 30 while still maintaining an Outperform rating. The latest downgrade to Neutral signals a more cautious near-term stance from the firm. The stock had already been under significant pressure from surging long-term Treasury yields over August 18-19, which weighed broadly on the semiconductor equipment sector, accumulating a decline exceeding 13% during that stretch. The current FactSet analyst consensus maintains an average overweight rating with a mean price target of $455.92, suggesting Baird's downgrade introduces further divergence among analysts regarding near-term valuation recovery potential.

Within the Semiconductor Equipment sector, Applied Materials fell 1.17%, KLA Corporation fell 0.84%, while Lam Research rose 0.13%, ASML Holding rose 0.03%, and AXT Inc rose 0.1%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10